Speciality Medicines Limited IPO
Speciality Medicines is engaged in the marketing and distribution of specialty pharmaceutical formulations, focusing on high-cost oral and injectable therapies used in the treatment of complex and chronic conditions. Its portfolio spans therapeutic areas such as oncology, immunology, neurology and rare diseases, with products available in diverse dosage forms including tablets, capsules, injections, infusions, inhalers, syrups and topical formulations. The Company operates through an integrated business model comprising contract manufacturing of approved formulations for international distribution and sourcing-based marketing and distribution of specialty pharmaceutical products. Through its diversified offerings, Speciality Medicines aims to address evolving
Price Band₹117 - ₹124 |
Dates20 Mar - 24 Mar |
GMP₹0 (0.00%) |
Subscriptions- |
Issue Size₹29.14 Crs |
Speciality Medicines IPO Key Dates
Opening Date
20 Mar 26
Closing Date
24 Mar 26
Basis Of Allotment
25 Mar 26
Initiations Of Refund
27 Mar 26
Credit Of Shares
27 Mar 26
Listing Date
30 Mar 26
Speciality Medicines IPO Objects
- Setting up of Research & Development (R&D) Center
- Product registration & Development in the international markets.
- Funding for Marketing & Brand Promotion Activities Promotional Activities.
- To Meet Working Capital Requirements.
- General Corporate Purposes
Speciality Medicines IPO Details
Price Band₹117 - ₹124 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹29.14 Cr (0.24 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹29.14 Cr (0.24 Cr Shares) |
Face Value₹10 per equity share |
Speciality Medicines IPO Lot Information
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
2
2,000
2,48,000
Maximum
2
2,000
2,48,000
|
|||
| Small HNI |
Minimum
3
3,000
3,72,000
Maximum
8
8,000
9,92,000
|
|||
| Big HNI |
Minimum
9
9,000
11,16,000
|
|||
Speciality Medicines IPO GMP
The estimated Grey Market Premium of Speciality Medicines IPO is ₹0 per share (0.00%)
Category Allocation
| Particulars | Allocation |
|---|---|
| QIB | Not more than 2% of Net Offer |
| NII | Not less than 49% of Net Offer |
| Retail | Not less than 49% of Net Offer |
| Market Maker | 1,50,000 EQ. Shares |
Speciality Medicines IPO Financials
| Particulars | Oct-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue | 36.72 | 58.27 | 27.52 | 23.18 |
| PAT | 6.06 | 8.61 | 2.93 | 1.70 |
| Net Worth | 36.47 | 30.42 | 15.06 | 5.93 |
| Borrowings | 4.81 | 5.05 | 2.86 | 3.64 |
| Assets | 45.57 | 39.98 | 22.68 | 13.26 |
| NAV (₹) | 56.67 | 47.07 | 29.44 | 15.53 |
| EPS (₹) | 9.41 | 14.10 | 7.07 | 4.74 |
The financial information presented is on a consolidated basis.
Key Performance Indicators
| KPI | VALUES |
|---|---|
| EBITDA | 15.60% |
| PAT | 14.77% |
| ROE | 37.85% |
| ROCE | 33.39% |
| Debt to Equity | 0.17 |
| PE Ratio | 8.79 |
| PB Ratio | 2.63 |
| Mkt Cap (in Crs.) | 108.94 |
- All the data pertains to FY 2024-25.
- PE, PB, and market capitalization are calculated based on the Upper Price Band.
Speciality Medicines IPO Peer Comparision
| Particulars | Speciality Medicines | Remus Pharma | Trident Lifeline | Mono Pharma |
|---|---|---|---|---|
| Revenue | 58.27 | 620.36 | 86.96 | 168.34 |
| PAT | 8.61 | 38.42 | 10.49 | 3.11 |
| EPS (₹) | 14.10 | 65.21 | 10.22 | 1.75 |
| NAV (₹) | 47.26 | 434.25 | 56.05 | 17.66 |
| RONW | 28.42% | 15.02% | 18.23% | 9.90% |
| EBITDA | 15.60% | 7.37% | 17.09% | 4.54% |
| PAT Mrgn | 14.77% | 6.19% | 12.07% | 1.84% |
| PE Ratio | 8.79 | 10.41 | 27.00 | 7.49 |
| Debt to Equity | 0.17 | 0.07 | 0.78 | 1.71 |
All information pertains to FY 2024-25. PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of February 24, 2026 for Peers
Speciality Medicines IPO Peer Comparision
| Particulars | Speciality Medicines |
|---|---|
| Revenue | 58.27 |
| PAT | 8.61 |
| EPS (₹) | 14.10 |
| NAV (₹) | 47.26 |
| RONW | 28.42% |
| EBITDA | 15.60% |
| PAT Mrgn | 14.77% |
| PE Ratio | 8.79 |
| Debt to Equity | 0.17 |
| Remus Pharma | Trident Lifeline | Mono Pharma |
|---|---|---|
| 620.36 | 86.96 | 168.34 |
| 38.42 | 10.49 | 3.11 |
| 65.21 | 10.22 | 1.75 |
| 434.25 | 56.05 | 17.66 |
| 15.02% | 18.23% | 9.90% |
| 7.37% | 17.09% | 4.54% |
| 6.19% | 12.07% | 1.84% |
| 10.41 | 27.00 | 7.49 |
| 0.07 | 0.78 | 1.71 |
All information pertains to FY 2024-25. PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of February 24, 2026 for Peers
Promoter Details
| Name | Shareholding |
|---|---|
| Parth Goyani | 28.83% |
| Sumit Goyani | 28.21% |
| Others | 2.24% |
| Total | 59.28% |
Management Details
| Name | Designation |
|---|---|
| Parth Goyani | Chairman & MD |
| Kalpesh Pipaliya | CFO |
Company Details
Name: Speciality Medicines Limited
Address: 913, One World West, S. No. 396, FP 119, Village- Vejalpur, Ahmedabad - 380051, Gujarat, India
Number: 022 4604 5344
Email: investors.grievances@spec ialitymedicine.com
Website: https://www.specialitymedicine.com
Book Running Lead Managers (BRLMs)
RTAs
Skyline Financial Services
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Speciality Medicines IPO is a SME IPO having an issue size of Rs. ₹29.14 Crs. Speciality Medicines IPO is priced at ₹117 - ₹124 per share. The issue opens on 20 Mar 26 and closes on 24 Mar 26.
Speciality Medicines IPO opens on 20 Mar 26 and closes on 24 Mar 26.
The estimated Grey Market Premium of Speciality Medicines IPO is ₹0 per share (0.00%).
The minimum lot size of Speciality Medicines IPO is 1000 shares & the minimum application amount is Rs. 124000.
The allotment date of Speciality Medicines IPO is 25 Mar 26.
The listing date of Speciality Medicines IPO is 30 Mar 26.
Speciality Medicines IPO is subscribed -.
Speciality Medicines IPO is priced at ₹117 - ₹124 per share.
Click the allotment link on Speciality Medicines IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Speciality Medicines IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
